Subsequent Events	6 Months Ended
Jun. 30, 2026
Subsequent Events [Abstract]
Subsequent Events	14. Subsequent Events Subsequent to quarter-end, the eXoZymes share price declined further, closing at $5.76 on August 12, 2026. Applying this price to the Company’s share position yields a fair value of $22.4 million – a decline of $11.3 million from the June 30, 2026 carrying value and $10.7 million below the fair value measured at June 30, 2026. Because this decline reflects market conditions and events arising after the balance sheet date rather than conditions that existed as of June 30, 2026, it represents a non-recognized (Type II) subsequent event under ASC 855-10-25. Management will disclose the magnitude and nature of this subsequent decline in the notes to the financial statements and will continue to monitor the position for purposes of the next reporting period’s impairment assessment.

The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 855
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/855/tableOfContent

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 855
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483399/855-10-50-2

Name:	us-gaap_SubsequentEventsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration